课题基金 / 基金详情

Pulmonary gamma-delta T cells in lung infection

Pulmonary gamma-delta T cells in lung infection
肺部感染中的肺 γ-δ T 细胞
批准号:
10623319
负责人:
Shelton Wiley Wright
金额:
$16.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-15 至 2026-05-31
关键词:
AddressAerosolsAnimal ModelApplications GrantsBacteriaBacterial VaccinesBlood donorBurkholderiaBurkholderia pseudomalleiCellsCessation of lifeCharacteristicsChildhoodComplementContainmentCritical IllnessDataDevelopmentDevelopment PlansDiseaseDisease modelFatality rateFc ReceptorGene ExpressionGenesGoalsHealthHospitalizationHost DefenseHost resistanceHumanIL17 geneImmune responseImmune systemImmunologyImmunotherapyImpairmentInfectionInflammationInflammatoryInflammatory ResponseIntensive CareInterferon Type IIK-Series Research Career ProgramsLeukocytesLower Respiratory Tract InfectionLungLung infectionsLymphocyteMelioidosisMentorsMentorshipMethodsModelingMucous MembraneMusNeutrophil InfiltrationPatient RecruitmentsPatientsPeripheralPhenotypePhysiciansPlayPneumoniaPositioning AttributeProcessProspective StudiesPulmonary InflammationReceptor CellResearchResearch PersonnelResearch Project GrantsRoleScientistSoilT cell responseT-Cell ActivationT-Cell ReceptorT-Lymphocyte SubsetsTestingTherapeuticTissuesTrainingTraining ProgramsTraining and InfrastructureUnited StatesUniversitiesWashingtonbioweaponcareer developmentcohortcommunity acquired pneumoniacytokinedifferential expressionhuman modelimmunomodulatory therapiesimprovedin vivoinnovationinsightknockout animalmouse modelmultidisciplinaryneutrophilnovelnovel therapeutic interventionpathogenperipheral bloodpneumonia modelprogramssingle-cell RNA sequencingskillstranscriptomicstranslational approachtranslational physiciantranslational research programtranslational scientistγδ T cells

项目摘要

项目成果

Shelton Wiley Wright的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Lower respiratory tract infections, including pneumonia, are the most common cause of infection-related death worldwide. γδ T cells are highly conserved leukocytes possessing innate-like immune response characteristics. Enriched in the mucosa, γδ T cells may play an outsized role in regulating pulmonary inflammatory responses and have been proposed as a basis for novel immunotherapies. However, data concerning the inflammatory role of pulmonary γδ T cells during pneumonia in humans are limited. Dr. Shelton Wright is a pediatric intensive care physician-scientist whose goal is to obtain the necessary training to become an independent translational investigator of pulmonary host defense. He has established a translational research program that has identified a critical role of γδ T cells in pulmonary melioidosis, a highly lethal cause of pneumonia. Based on these findings, he has developed a central hypothesis that host resistance to pulmonary melioidosis is dependent on an IL-17+ γδ T cell inflammatory response. Dr. Wright's research goal is to determine the mechanisms underlying the host γδ T cell inflammatory response during severe lung infection. Using pulmonary melioidosis as a model for severe lung infection, Dr. Wright will test his hypothesis through the following 3 Aims: 1) Determine the role of γδ T cells in lung inflammation during pulmonary melioidosis in vivo; 2) Identify differential human γδ T cell inflammatory responses to B. pseudomallei infection in the ex-vivo lung compared to peripheral blood; and 3) Characterize γδ T cell activation in patients with early pulmonary melioidosis. The Career Development Plan for this grant proposal will provide Dr. Wright with critical training in pulmonary immunology, transcriptomics and high containment pathogen research. Dr. Wright has leveraged the outstanding training infrastructure at the University of Washington and its affiliates to bring together a wide array of experts in these fields to provide targeted mentorship for this proposal. Dr. Wright's multidisciplinary team of mentors will greatly complement his proposed research project along with a carefully selected didactic program. The data generated by his proposal and the skillsets developed from his training program will significantly facilitate Dr. Wright's goal of developing into an independent translational physician-scientist investigating the mechanisms of pulmonary host defense during severe lung infection.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s2214-109x(22)00277-7
发表时间: 2022-09
期刊: LANCET GLOBAL HEALTH
影响因子: 34.3
作者: [Wright, Shelton W., Hantrakun, Viriya, Rudd, Kristina E., Lau, Chuen-Yen, Lie, Khie Chen, Nguyen Van Vinh Chau, Teparrukkul, Prapit, West, T. Eoin, Limmathurotsakul, Direk]
通讯作者: Limmathurotsakul, Direk
IL-1R2-based biomarker models predict melioidosis mortality independent of clinical data.
基于IL-1R2的生物标志物模型可预测与临床数据无关的黑胶病死亡率。
DOI: 10.3389/fmed.2023.1211265
发表时间: 2023
期刊: Frontiers in medicine
影响因子: 3.9
作者: []
通讯作者:
Pulmonary gamma-delta T cells in lung infection
  • 批准号:
    10187880
  • 项目类别:
  • 资助金额:
    $16.08万
  • 财政年份:
    2021
  • 负责人:
    Shelton Wiley Wright
  • 依托单位:
Pulmonary gamma-delta T cells in lung infection
  • 批准号:
    10424454
  • 项目类别:
  • 资助金额:
    $16.08万
  • 财政年份:
    2021
  • 负责人:
    Shelton Wiley Wright
  • 依托单位:
海外基金